updating data for batch codes

This commit is contained in:
no name
2024-09-13 16:19:27 +00:00
parent 07f29e275c
commit 1338bc1ff5
9419 changed files with 6705 additions and 9420 deletions

View File

@@ -1 +1 @@
{"blood glucose abnormal": 52.1, "blood glucose decreased": 19.48, "blood glucose fluctuation": 77.01, "blood glucose increased": 61.15, "dermatitis allergic": 4.19, "device breakage": 17.24, "device defective": 40.82, "device delivery system issue": 55.51, "device failure": 69.36, "device information output issue": 292.48, "device issue": 33.17, "device leakage": 25.07, "device malfunction": 26.02, "device mechanical issue": 83.42, "device occlusion": 33.1, "diabetes mellitus inadequate control": 21.7, "diabetic ketoacidosis": 13.29, "diabetic metabolic decompensation": 47.11, "drug delivery system issue": 58.74, "drug ineffective": 8.19, "exposure during pregcy": 2.4, "extra dose administered": 11.22, "glycosylated haemoglobin increased": 9.1, "hyperglycaemia": 66.19, "hypoglycaemia": 26.1, "hypoglycaemic unconsciousness": 18.55, "incorrect dose administered": 2.28, "incorrect dose administered by device": 127.9, "increased insulin requirement": 303.04, "infusion site erythema": 36.08, "infusion site inflammation": 90.96, "infusion site pain": 108.32, "injection site atrophy": 57.02, "injection site bruising": 8.05, "injection site haemorrhage": 7.18, "injection site hypersensitivity": 20.24, "injection site irritation": 29.35, "injection site mass": 6.57, "injection site pruritus": 2.17, "injection site rash": 5.42, "insulin resistance": 66.82, "ketoacidosis": 6.93, "liquid product physical issue": 510.84, "maternal exposure during pregcy": 3.3, "product appearance confusion": 259.62, "product colour issue": 43.33, "product contamination with body fluid": 344.31, "product deposit": 205.32, "product gel formation": 2378.99, "product leakage": 60.37, "product physical issue": 59.38, "product quality issue": 38.14, "product storage error": 18.91, "therapeutic product effect decreased": 16.35, "therapeutic product effect delayed": 126.82, "therapeutic product effect variable": 82.33, "thirst": 3.19, "wrong product administered": 37.4, "wrong technique in device usage process": 8.31, "wrong technique in product usage process": 9.89}
{"multiple sclerosis relapse": 23.8, "product substitution issue": 137.57}